Laurence Turka

Laurence Turka is a seasoned professional in the medical and scientific fields, currently serving on the Board of Directors at HaemaLogiX Ltd since February 2024. With a longstanding role as a Physician/Scientist at Massachusetts General Hospital since January 2013, Laurence has held prominent leadership positions, including Chief Scientific Officer at Rubius Therapeutics from January 2020 to February 2023 and Chief Scientific Officer at Rheos Medicines, Inc. from March 2018 to January 2020. Laurence earned a Doctor of Medicine (MD) degree in Medicine from Yale University, completing education in June 1982.